Companies: 10,795·Total market cap: $144.5T
Inventiva S.A.

Inventiva S.A.

IVEVFOTCHealthcare● Active
$4.00
$-1.33(-24.95%)
Market Cap$556245172
P/E Ratio
52W High$5.75
52W Low$2.28
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Inventiva S.A. (IVEVF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001756594 · IVEVF · OTC · as of Jun 8, 2026

Filing snapshot

216
Total Filings
6-K
Latest Form
2026-06-03
Most Recent
2019
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001756594 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-08
Fiscal Year End
Apr 8, 2026
Accession No.
0001104659-26-040704
Primary Document
iva-20251231x20f.htm
Source: data.sec.gov · CIK 0001756594 · Accession 0001104659-26-040704

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-03
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-03
View
424B5424B5
424B5
2026-06-02
View
FWPFWP
FWP
2026-06-02
View
F-3ASRF-3ASR
F-3ASR
2026-06-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-22
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-22
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-08
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
Showing 1–15 of 216 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001756594  |  Exchange: OTC · Healthcare

Inventiva S.A. (OTC: IVEVF) has submitted 216 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001756594, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Inventiva S.A.'s most comprehensive regulatory disclosure. The most recent Inventiva S.A. 10-K was filed on 2026-04-08 for fiscal year ending 2026. Historical IVEVF 10-K annual reports are available from 2020 through 2026.

Investors researching Inventiva S.A. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

IVEVF SEC Filings · 8 questions

Inventiva S.A. (IVEVF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 216 filings and access original documents at no cost. Inventiva S.A.'s CIK is 0001756594.

IVEVF SEC filingsInventiva S.A. SEC documentsfind IVEVF 10-K